These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36994865)

  • 1. Timing and frequency of oropharyngeal squamous cell carcinoma recurrences after treatment with curative intent.
    Autio TJ; Atula T; Jouhi L; Irjala H; Halme E; Jouppila-Mättö A; Mäkitie A; Koivunen P
    Acta Otolaryngol; 2023 Apr; 143(4):328-333. PubMed ID: 36994865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of routine follow-up in oropharyngeal squamous cell cancer patients treated with curative intent.
    Brands MT; Swinkels IJ; Aarts AMWM; Verbeek ALM; Merkx MAW; Marres HAM; Kaanders JHAM; Melchers WJG; van Engen-van Grunsven I; Takes RP; Geurts SME
    Head Neck; 2023 Mar; 45(3):586-594. PubMed ID: 36565244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.
    Jouhi L; Halme E; Irjala H; Saarilahti K; Koivunen P; Pukkila M; Hagström J; Haglund C; Lindholm P; Hirvikoski P; Vaittinen S; Ellonen A; Tikanto J; Blomster H; Laranne J; Grénman R; Mäkitie A; Atula T
    Acta Oncol; 2018 Apr; 57(4):541-551. PubMed ID: 29145765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
    Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
    Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
    Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
    Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
    J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
    Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
    Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution's experience.
    Jiromaru R; Yasumatsu R; Yamamoto H; Kuga R; Hongo T; Nakano T; Manako T; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3717-3725. PubMed ID: 34978590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
    Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
    Saito Y; Hayashi R; Iida Y; Mizumachi T; Fujii T; Matsumoto F; Beppu T; Yoshida M; Shinomiya H; Kamiyama R; Kitano M; Yokoshima K; Fujimoto Y; Hama T; Yamashita T; Okami K; Miura K; Fujisawa T; Sano D; Kato H; Minami S; Sugasawa M; Masuda M; Ota I; Iwae S; Kawata R; Monden N; Imai T; Asakage T; Okada M; Yoshikawa T; Tanioka K; Kitayama M; Doi M; Fujii S; Fujii M; Oridate N; Nakamizo M; Yoshimoto S; Homma A; Nibu KI; Yane K
    Cancer; 2020 Sep; 126(18):4177-4187. PubMed ID: 32648953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.